Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.
USANA Health Sciences, Inc. (NYSE: USNA) is a global nutrition company that develops and manufactures nutritional supplements, functional foods, personal care products, skincare, and healthy living products. This news page aggregates coverage of USANA’s announcements, giving readers a focused view of how the company communicates about its business, products, and strategic priorities.
Investors and observers can use this page to follow USANA’s updates on net sales outlooks, segment performance, and guidance, as reflected in press releases tied to events such as investor conferences and quarterly results. The company issues news on its direct selling operations, its Hiya direct-to-consumer segment, and its Rise Wellness business, including commentary on growth expectations, investments in inventory and capital expenditures, and integration initiatives.
USANA also publishes product-focused news, such as third-party certifications for its Probiotic and MagneCal D supplements, which have earned the ConsumerLab.com Seal of Approval. These items highlight the company’s emphasis on purity, potency, and scientific standards for its nutritional products. Additional stories cover partnerships, including its collaboration with the Jamaica Bobsleigh and Skeleton Federation, and community initiatives led by the USANA Foundation to address food insecurity.
Leadership and culture are recurring themes in USANA’s communications, with messages from its Executive Chairman and CEO on growth mindset, values-based leadership, and social wellness. By visiting this page regularly, readers can track how USANA presents its strategy, product quality, philanthropy, and international footprint through official news releases.
USANA Health Sciences (NYSE: USNA) has reported preliminary Q2 2022 net sales of approximately
On July 6, 2022, Kevin Guest, CEO of USANA Health Sciences (NYSE: USNA), highlighted the significance of International Peace and Love Day on July 7, emphasizing the benefits of peace and kindness for reducing stress and boosting productivity. He shared seven strategies to enhance workplace culture and personal well-being, including mindfulness and gratitude practices. Guest’s book, All the Right Reasons, supports feeding two million meals to hungry children through its sales. The insights aim to foster a healthier, more productive environment both individually and organizationally.
USANA recently held a joint research symposium on Traditional Chinese Medicine (TCM) in Maryland, partnering with the US Center for Chinese Medicine. This initiative aims to integrate TCM with modern wellness practices, showcasing USANA's commitment to exploring TCM efficacy. The company is collaborating with Beijing University of Chinese Medicine to research TCM's ability to replenish Qi and develop new health products tailored to various body types. The research program is in its second year of a five-year agreement.
USANA is pleased to announce that two members of its legal team have been recognized by Utah Business magazine. Chief Legal Officer Joshua Foukas received the CXO of the Year award, while Corporate Counsel Elise Walker Brown was honored as one of the 30 Women to Watch. Foukas has been instrumental in driving changes at USANA since joining in 2007, while Brown, who joined in 2020, has significantly contributed to diversity and inclusion efforts. These awards highlight USANA's commitment to professional excellence within its leadership team.
USANA Health Sciences CEO Kevin Guest recognizes World Day of Music on June 21 by highlighting music's positive effects on mood and productivity. Guest shares five insights on how music can alleviate stress and enhance workplace harmony. He explains his personal connection to music and encourages the use of both listening and dancing to improve well-being. Additionally, proceeds from his book, All the Right Reasons, aim to provide meals for hungry children, reinforcing the importance of social responsibility.
On June 1, 2022, USANA CEO Kevin Guest discussed the challenges of restoring corporate culture post-pandemic. He emphasizes aligning personal values with company culture to foster harmony. Guest outlines eight steps for leaders to strengthen their organizations, including enhancing communication, giving praise, and building community ties. USANA's non-profit, the USANA Foundation, aims to combat starvation in 37 countries. Guest's book, All the Right Reasons, directs proceeds to provide meals for children in need, promoting a culture of service and teamwork.
USANA Becomes Official Nutritional Supplier for Basketball New Zealand
On May 31, 2022, USANA announced its partnership as the official nutritional supplement supplier for the Tall Blacks and Sky Sport Tall Ferns, providing NSF-certified products. This collaboration supports athletes as they prepare for upcoming competitions, including the FIBA Asia Cup and Birmingham 2022 Commonwealth Games. USANA’s products are validated through rigorous third-party testing, ensuring compliance with the World Anti-Doping Agency's standards. This partnership signifies USANA's commitment to quality and athlete health.
USANA celebrated success at the Best of State Gala in Salt Lake City, winning four prestigious awards for excellence in product quality and innovation. Notable wins include the Celavive skincare system, Rev3 Energy, CellSentials, and its Nutritional product line. USANA has been recognized for its high-quality, science-based supplements, marking its 30th anniversary this year. Since 1992, it has received over 850 awards globally, reflecting its commitment to improving health and nutrition.
Summary not available.
USANA Health Sciences reported Q1 2022 financial results with net sales of $273 million, a decline of 11% from $308 million in Q1 2021. Diluted EPS fell 21% to $1.15. The company revised its fiscal 2022 outlook to net sales of $1.1 billion to $1.2 billion and diluted EPS of $5.00 to $5.70. Challenges arose from COVID-19 disruptions in Asia Pacific, particularly China. The company ended the quarter with $238 million in cash after repurchasing shares worth $25 million.